PRA Health Sciences was selected to conduct a global program of studies that targeted 2,200+ patients with multiple sclerosis (MS). Although there were many challenges, the study team implemented a comprehensive risk-management plan that resulted in achieved recruitment goals and positioned the sponsor as a “Sponsor of Choice” in MS research.
PRA Cool Under Deadline Pressure
PRA was selected to perform a Phase II colorectal cancer trial due to our knowledge from previous colorectal studies as well as our evidence-based…
PRA Successfully Delivers A Complex Phase I Psoriasis Study
Exceptional Support and Innovative Strategies Combat Study Challenges.
Oncology University Fact Sheet
PRA Health Sciences has responded to the industry’s urgent need to find the right CRAs for oncology research with our new Oncology University. This…